Activated Partial Thromboplastin Test Market - Global Outlook and Forecast 2022-2028

January 2022 | 64 pages | ID: A68A720620C4EN
Market Monitor Global

Abstracts

Activated Partial Thromboplastin Test is mainly used to measure coagulation cascade i.e. blood clotting which is mainly derived from the original form of test in which only phospholipids concentration of test was controlled.

This report contains market size and forecasts of Activated Partial Thromboplastin Test in Global, including the following market information:

Global Activated Partial Thromboplastin Test Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Activated Partial Thromboplastin Test market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Optical Technology Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Activated Partial Thromboplastin Test include Horiba International, Bio-Rad Laboratories, Johnson & Johnson, Siemens Medical Solutions, Abbott Laboratories, BioMeriux, Eiken Chemical, Life Technologies and Danaher, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Activated Partial Thromboplastin Test companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Activated Partial Thromboplastin Test Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Activated Partial Thromboplastin Test Market Segment Percentages, by Type, 2021 (%)

• Optical Technology
• Mechanical Technology
• Electrochemical Technology

Global Activated Partial Thromboplastin Test Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Activated Partial Thromboplastin Test Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Others

Global Activated Partial Thromboplastin Test Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Activated Partial Thromboplastin Test Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Activated Partial Thromboplastin Test revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Activated Partial Thromboplastin Test revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Horiba International
• Bio-Rad Laboratories
• Johnson & Johnson
• Siemens Medical Solutions
• Abbott Laboratories
• BioMeriux
• Eiken Chemical
• Life Technologies
• Danaher
• BD
• Roche Diagnostics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Activated Partial Thromboplastin Test Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Activated Partial Thromboplastin Test Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ACTIVATED PARTIAL THROMBOPLASTIN TEST OVERALL MARKET SIZE

2.1 Global Activated Partial Thromboplastin Test Market Size: 2021 VS 2028
2.2 Global Activated Partial Thromboplastin Test Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Activated Partial Thromboplastin Test Players in Global Market
3.2 Top Global Activated Partial Thromboplastin Test Companies Ranked by Revenue
3.3 Global Activated Partial Thromboplastin Test Revenue by Companies
3.4 Top 3 and Top 5 Activated Partial Thromboplastin Test Companies in Global Market, by Revenue in 2021
3.5 Global Companies Activated Partial Thromboplastin Test Product Type
3.6 Tier 1, Tier 2 and Tier 3 Activated Partial Thromboplastin Test Players in Global Market
  3.6.1 List of Global Tier 1 Activated Partial Thromboplastin Test Companies
  3.6.2 List of Global Tier 2 and Tier 3 Activated Partial Thromboplastin Test Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Activated Partial Thromboplastin Test Market Size Markets, 2021 & 2028
  4.1.2 Optical Technology
  4.1.3 Mechanical Technology
  4.1.4 Electrochemical Technology
4.2 By Type - Global Activated Partial Thromboplastin Test Revenue & Forecasts
  4.2.1 By Type - Global Activated Partial Thromboplastin Test Revenue, 2017-2022
  4.2.2 By Type - Global Activated Partial Thromboplastin Test Revenue, 2023-2028
  4.2.3 By Type - Global Activated Partial Thromboplastin Test Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Activated Partial Thromboplastin Test Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Others
5.2 By Application - Global Activated Partial Thromboplastin Test Revenue & Forecasts
  5.2.1 By Application - Global Activated Partial Thromboplastin Test Revenue, 2017-2022
  5.2.2 By Application - Global Activated Partial Thromboplastin Test Revenue, 2023-2028
  5.2.3 By Application - Global Activated Partial Thromboplastin Test Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Activated Partial Thromboplastin Test Market Size, 2021 & 2028
6.2 By Region - Global Activated Partial Thromboplastin Test Revenue & Forecasts
  6.2.1 By Region - Global Activated Partial Thromboplastin Test Revenue, 2017-2022
  6.2.2 By Region - Global Activated Partial Thromboplastin Test Revenue, 2023-2028
  6.2.3 By Region - Global Activated Partial Thromboplastin Test Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Activated Partial Thromboplastin Test Revenue, 2017-2028
  6.3.2 US Activated Partial Thromboplastin Test Market Size, 2017-2028
  6.3.3 Canada Activated Partial Thromboplastin Test Market Size, 2017-2028
  6.3.4 Mexico Activated Partial Thromboplastin Test Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Activated Partial Thromboplastin Test Revenue, 2017-2028
  6.4.2 Germany Activated Partial Thromboplastin Test Market Size, 2017-2028
  6.4.3 France Activated Partial Thromboplastin Test Market Size, 2017-2028
  6.4.4 U.K. Activated Partial Thromboplastin Test Market Size, 2017-2028
  6.4.5 Italy Activated Partial Thromboplastin Test Market Size, 2017-2028
  6.4.6 Russia Activated Partial Thromboplastin Test Market Size, 2017-2028
  6.4.7 Nordic Countries Activated Partial Thromboplastin Test Market Size, 2017-2028
  6.4.8 Benelux Activated Partial Thromboplastin Test Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Activated Partial Thromboplastin Test Revenue, 2017-2028
  6.5.2 China Activated Partial Thromboplastin Test Market Size, 2017-2028
  6.5.3 Japan Activated Partial Thromboplastin Test Market Size, 2017-2028
  6.5.4 South Korea Activated Partial Thromboplastin Test Market Size, 2017-2028
  6.5.5 Southeast Asia Activated Partial Thromboplastin Test Market Size, 2017-2028
  6.5.6 India Activated Partial Thromboplastin Test Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Activated Partial Thromboplastin Test Revenue, 2017-2028
  6.6.2 Brazil Activated Partial Thromboplastin Test Market Size, 2017-2028
  6.6.3 Argentina Activated Partial Thromboplastin Test Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Activated Partial Thromboplastin Test Revenue, 2017-2028
  6.7.2 Turkey Activated Partial Thromboplastin Test Market Size, 2017-2028
  6.7.3 Israel Activated Partial Thromboplastin Test Market Size, 2017-2028
  6.7.4 Saudi Arabia Activated Partial Thromboplastin Test Market Size, 2017-2028
  6.7.5 UAE Activated Partial Thromboplastin Test Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Horiba International
  7.1.1 Horiba International Corporate Summary
  7.1.2 Horiba International Business Overview
  7.1.3 Horiba International Activated Partial Thromboplastin Test Major Product Offerings
  7.1.4 Horiba International Activated Partial Thromboplastin Test Revenue in Global Market (2017-2022)
  7.1.5 Horiba International Key News
7.2 Bio-Rad Laboratories
  7.2.1 Bio-Rad Laboratories Corporate Summary
  7.2.2 Bio-Rad Laboratories Business Overview
  7.2.3 Bio-Rad Laboratories Activated Partial Thromboplastin Test Major Product Offerings
  7.2.4 Bio-Rad Laboratories Activated Partial Thromboplastin Test Revenue in Global Market (2017-2022)
  7.2.5 Bio-Rad Laboratories Key News
7.3 Johnson & Johnson
  7.3.1 Johnson & Johnson Corporate Summary
  7.3.2 Johnson & Johnson Business Overview
  7.3.3 Johnson & Johnson Activated Partial Thromboplastin Test Major Product Offerings
  7.3.4 Johnson & Johnson Activated Partial Thromboplastin Test Revenue in Global Market (2017-2022)
  7.3.5 Johnson & Johnson Key News
7.4 Siemens Medical Solutions
  7.4.1 Siemens Medical Solutions Corporate Summary
  7.4.2 Siemens Medical Solutions Business Overview
  7.4.3 Siemens Medical Solutions Activated Partial Thromboplastin Test Major Product Offerings
  7.4.4 Siemens Medical Solutions Activated Partial Thromboplastin Test Revenue in Global Market (2017-2022)
  7.4.5 Siemens Medical Solutions Key News
7.5 Abbott Laboratories
  7.5.1 Abbott Laboratories Corporate Summary
  7.5.2 Abbott Laboratories Business Overview
  7.5.3 Abbott Laboratories Activated Partial Thromboplastin Test Major Product Offerings
  7.5.4 Abbott Laboratories Activated Partial Thromboplastin Test Revenue in Global Market (2017-2022)
  7.5.5 Abbott Laboratories Key News
7.6 BioMeriux
  7.6.1 BioMeriux Corporate Summary
  7.6.2 BioMeriux Business Overview
  7.6.3 BioMeriux Activated Partial Thromboplastin Test Major Product Offerings
  7.6.4 BioMeriux Activated Partial Thromboplastin Test Revenue in Global Market (2017-2022)
  7.6.5 BioMeriux Key News
7.7 Eiken Chemical
  7.7.1 Eiken Chemical Corporate Summary
  7.7.2 Eiken Chemical Business Overview
  7.7.3 Eiken Chemical Activated Partial Thromboplastin Test Major Product Offerings
  7.7.4 Eiken Chemical Activated Partial Thromboplastin Test Revenue in Global Market (2017-2022)
  7.7.5 Eiken Chemical Key News
7.8 Life Technologies
  7.8.1 Life Technologies Corporate Summary
  7.8.2 Life Technologies Business Overview
  7.8.3 Life Technologies Activated Partial Thromboplastin Test Major Product Offerings
  7.8.4 Life Technologies Activated Partial Thromboplastin Test Revenue in Global Market (2017-2022)
  7.8.5 Life Technologies Key News
7.9 Danaher
  7.9.1 Danaher Corporate Summary
  7.9.2 Danaher Business Overview
  7.9.3 Danaher Activated Partial Thromboplastin Test Major Product Offerings
  7.9.4 Danaher Activated Partial Thromboplastin Test Revenue in Global Market (2017-2022)
  7.9.5 Danaher Key News
7.10 BD
  7.10.1 BD Corporate Summary
  7.10.2 BD Business Overview
  7.10.3 BD Activated Partial Thromboplastin Test Major Product Offerings
  7.10.4 BD Activated Partial Thromboplastin Test Revenue in Global Market (2017-2022)
  7.10.5 BD Key News
7.11 Roche Diagnostics
  7.11.1 Roche Diagnostics Corporate Summary
  7.11.2 Roche Diagnostics Business Overview
  7.11.3 Roche Diagnostics Activated Partial Thromboplastin Test Major Product Offerings
  7.11.4 Roche Diagnostics Activated Partial Thromboplastin Test Revenue in Global Market (2017-2022)
  7.11.5 Roche Diagnostics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Activated Partial Thromboplastin Test Market Opportunities & Trends in Global Market
Table 2. Activated Partial Thromboplastin Test Market Drivers in Global Market
Table 3. Activated Partial Thromboplastin Test Market Restraints in Global Market
Table 4. Key Players of Activated Partial Thromboplastin Test in Global Market
Table 5. Top Activated Partial Thromboplastin Test Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Activated Partial Thromboplastin Test Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Activated Partial Thromboplastin Test Revenue Share by Companies, 2017-2022
Table 8. Global Companies Activated Partial Thromboplastin Test Product Type
Table 9. List of Global Tier 1 Activated Partial Thromboplastin Test Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Activated Partial Thromboplastin Test Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Activated Partial Thromboplastin Test Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Activated Partial Thromboplastin Test Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Activated Partial Thromboplastin Test Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Activated Partial Thromboplastin Test Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Activated Partial Thromboplastin Test Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Activated Partial Thromboplastin Test Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Activated Partial Thromboplastin Test Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Activated Partial Thromboplastin Test Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Activated Partial Thromboplastin Test Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Activated Partial Thromboplastin Test Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Activated Partial Thromboplastin Test Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Activated Partial Thromboplastin Test Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Activated Partial Thromboplastin Test Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Activated Partial Thromboplastin Test Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Activated Partial Thromboplastin Test Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Activated Partial Thromboplastin Test Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Activated Partial Thromboplastin Test Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Activated Partial Thromboplastin Test Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Activated Partial Thromboplastin Test Revenue, (US$, Mn), 2023-2028
Table 30. Horiba International Corporate Summary
Table 31. Horiba International Activated Partial Thromboplastin Test Product Offerings
Table 32. Horiba International Activated Partial Thromboplastin Test Revenue (US$, Mn), (2017-2022)
Table 33. Bio-Rad Laboratories Corporate Summary
Table 34. Bio-Rad Laboratories Activated Partial Thromboplastin Test Product Offerings
Table 35. Bio-Rad Laboratories Activated Partial Thromboplastin Test Revenue (US$, Mn), (2017-2022)
Table 36. Johnson & Johnson Corporate Summary
Table 37. Johnson & Johnson Activated Partial Thromboplastin Test Product Offerings
Table 38. Johnson & Johnson Activated Partial Thromboplastin Test Revenue (US$, Mn), (2017-2022)
Table 39. Siemens Medical Solutions Corporate Summary
Table 40. Siemens Medical Solutions Activated Partial Thromboplastin Test Product Offerings
Table 41. Siemens Medical Solutions Activated Partial Thromboplastin Test Revenue (US$, Mn), (2017-2022)
Table 42. Abbott Laboratories Corporate Summary
Table 43. Abbott Laboratories Activated Partial Thromboplastin Test Product Offerings
Table 44. Abbott Laboratories Activated Partial Thromboplastin Test Revenue (US$, Mn), (2017-2022)
Table 45. BioMeriux Corporate Summary
Table 46. BioMeriux Activated Partial Thromboplastin Test Product Offerings
Table 47. BioMeriux Activated Partial Thromboplastin Test Revenue (US$, Mn), (2017-2022)
Table 48. Eiken Chemical Corporate Summary
Table 49. Eiken Chemical Activated Partial Thromboplastin Test Product Offerings
Table 50. Eiken Chemical Activated Partial Thromboplastin Test Revenue (US$, Mn), (2017-2022)
Table 51. Life Technologies Corporate Summary
Table 52. Life Technologies Activated Partial Thromboplastin Test Product Offerings
Table 53. Life Technologies Activated Partial Thromboplastin Test Revenue (US$, Mn), (2017-2022)
Table 54. Danaher Corporate Summary
Table 55. Danaher Activated Partial Thromboplastin Test Product Offerings
Table 56. Danaher Activated Partial Thromboplastin Test Revenue (US$, Mn), (2017-2022)
Table 57. BD Corporate Summary
Table 58. BD Activated Partial Thromboplastin Test Product Offerings
Table 59. BD Activated Partial Thromboplastin Test Revenue (US$, Mn), (2017-2022)
Table 60. Roche Diagnostics Corporate Summary
Table 61. Roche Diagnostics Activated Partial Thromboplastin Test Product Offerings
Table 62. Roche Diagnostics Activated Partial Thromboplastin Test Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Activated Partial Thromboplastin Test Segment by Type in 2021
Figure 2. Activated Partial Thromboplastin Test Segment by Application in 2021
Figure 3. Global Activated Partial Thromboplastin Test Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Activated Partial Thromboplastin Test Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Activated Partial Thromboplastin Test Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Activated Partial Thromboplastin Test Revenue in 2021
Figure 8. By Type - Global Activated Partial Thromboplastin Test Revenue Market Share, 2017-2028
Figure 9. By Application - Global Activated Partial Thromboplastin Test Revenue Market Share, 2017-2028
Figure 10. By Region - Global Activated Partial Thromboplastin Test Revenue Market Share, 2017-2028
Figure 11. By Country - North America Activated Partial Thromboplastin Test Revenue Market Share, 2017-2028
Figure 12. US Activated Partial Thromboplastin Test Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Activated Partial Thromboplastin Test Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Activated Partial Thromboplastin Test Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Activated Partial Thromboplastin Test Revenue Market Share, 2017-2028
Figure 16. Germany Activated Partial Thromboplastin Test Revenue, (US$, Mn), 2017-2028
Figure 17. France Activated Partial Thromboplastin Test Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Activated Partial Thromboplastin Test Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Activated Partial Thromboplastin Test Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Activated Partial Thromboplastin Test Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Activated Partial Thromboplastin Test Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Activated Partial Thromboplastin Test Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Activated Partial Thromboplastin Test Revenue Market Share, 2017-2028
Figure 24. China Activated Partial Thromboplastin Test Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Activated Partial Thromboplastin Test Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Activated Partial Thromboplastin Test Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Activated Partial Thromboplastin Test Revenue, (US$, Mn), 2017-2028
Figure 28. India Activated Partial Thromboplastin Test Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Activated Partial Thromboplastin Test Revenue Market Share, 2017-2028
Figure 30. Brazil Activated Partial Thromboplastin Test Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Activated Partial Thromboplastin Test Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Activated Partial Thromboplastin Test Revenue Market Share, 2017-2028
Figure 33. Turkey Activated Partial Thromboplastin Test Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Activated Partial Thromboplastin Test Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Activated Partial Thromboplastin Test Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Activated Partial Thromboplastin Test Revenue, (US$, Mn), 2017-2028
Figure 37. Horiba International Activated Partial Thromboplastin Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bio-Rad Laboratories Activated Partial Thromboplastin Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Johnson & Johnson Activated Partial Thromboplastin Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Siemens Medical Solutions Activated Partial Thromboplastin Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Abbott Laboratories Activated Partial Thromboplastin Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. BioMeriux Activated Partial Thromboplastin Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Eiken Chemical Activated Partial Thromboplastin Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Life Technologies Activated Partial Thromboplastin Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Danaher Activated Partial Thromboplastin Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. BD Activated Partial Thromboplastin Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Roche Diagnostics Activated Partial Thromboplastin Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)